Summa Cum Laude/Golden Medal, Yerevan State Medical University
Mkhitar Heratsi Award: “Best Medical Student, Class of 1993,” Armenia
Bejanyan N, Lazaryan A, Rybicki L, Tench S, Duong H, Andresen S, Sobecks R, Dean R, Pohlman B, Kalaycio M, Bolwell B, and Copelan E. Risk Factors for 30-Day Hospital Readmission Following Myeloablative Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2012 Jun;18(6):874-80. Epub 2011 Oct 29.
Bejanyan N, Fu A, Lazaryan A, Rao F, Kalaycio M, Advani A, Sobecks R, Copelan E, Sekeres M. Impact of Weekend Admissions on Quality of Care and Outcomes in Patients with Acute Myeloid Leukemia (AML). Cancer, 2010 Aug 1;116 (15):3614-20.
Bejanyan N, Tiu R, Raza A, Jankowska A, Kalaycio M, Advani A, Chan J, Saunthararajah Y,Mooney L, Maciejewski J, and Sekeres M. A Phase II Trial of Combination Therapy with Thalidomide, Arsenic Trioxide, Dexamethasone, and Ascorbic Acid (TADA) in Patients with Overlap Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) or Primary Myelofibrosis (PMF). Cancer. 2011 Dec 16. doi: 10.1002/cncr.26741.
Bejanyan N, Sekeres M. The revolution of myelodysplastic syndromes. Therapeutic Advances in Hematology. February 1, 2011; 2(1): 33
Clemente M, Wlodarski M, Makishima H, Viny A, Bretschneider I, Shaik M, Bejanyan N, Lichtin A, His E, Paquette R, Loughran T, Maciejewski J. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood. 2011 Oct 20;118(16):4384-93. Epub 2011 Aug 24.
Discrimination is Against the Law. We comply with applicable Federal civil rights laws and Minnesota laws. We do not discriminate against, exclude or treat people differently because of race, color, national origin, age, disability, sex, sexual orientation or gender identity. Please see our Patients’ Bill of Rights.